Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)
QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute
Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics
Regeneron And Colorado Center For Personalized Medicine Announce Major New Human Genetics Research Collaboration
BioIT 2019: The New “Official” Future Involves Data Sharing, Artificial Intelligence, Open Source, and More